← Back to all trials
Active Not Recruiting
NCT04403984
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
Conditions: Breast Cancer
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 750
Sponsor: Hellenic Cooperative Oncology Group
Location: George Fountzilas Athens
Summary
This is a translational study in patients with operated early breast cancer of Luminal A or Luminal B sub types.The Hellenic Cooperative Oncology Group (HeCOG) has designed an observational biomarker-driven study in patients with Luminal A or Luminal B breast cancer, with the aim to collect valuable biological material from these patients and investigate biomarkers with potential prognostic value.
Eligibility Criteria
Inclusion Criteria:
* 18 years old or older
* Luminal A breast cancer sub type
* Luminal B breast cancer sub type
* Positive lymph nodes
* Node- negative with tumor stage or pathological features according to Saint Gallen guidelines.
Exclusion Criteria:
\-
Source: ClinicalTrials.gov (NCT04403984). StuddyBuddy aggregates publicly available trial information.
